Clinical Trial Detail

NCT ID NCT01005797
Title Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements no
Sponsors Medical University of South Carolina
Indications

non-small cell lung carcinoma

sarcoma

kidney cancer

Therapies

Panobinostat + Sorafenib

Age Groups: adult

No variant requirements are available.